← Open Payments lookup

NICK RAMANDI: Open Payments

NPI 1124219050 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,920 in 17 payments from 9 companies in 2025. Trend: 2023 $911 · 2024 $2,062 · 2025 $1,920

Food & beverage: $1,920
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$365
Alkermes, Inc.3$306
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$242
ABBVIE INC.2$240
Axsome Therapeutics, Inc.2$234
E.R. Squibb & Sons, L.L.C.2$215
Collegium Pharmaceutical, Inc.1$125
Teva Pharmaceuticals USA, Inc.1$102
Boehringer Ingelheim Pharmaceuticals, Inc.1$91

Products named: ABILIFY MAINTENA, CAPLYTA, VRAYLAR, Auvelity, COBENFY, Jornay PM, REXULTI, ARISTADA.

Industry payments across LA — which companies pay providers there.